Table 2: Intravascular Ultrasound (IVUS) findings according to the presence or absence of events after PEB angioplasty (n = 58).
Variables | non-PEB failure (n = 50) | PEB failure (n = 8) | P-value |
mean ± SD or n (%) | |||
Proximal reference segment | |||
EEM CSA, mm2 | 13.8 ± 4.10 | 14.4 ± 3.40 | 0.58 |
Lumen CSA, mm2 | 6.3 ± 1.9 | 6.4 ± 1.3 | 0.21 |
P&M CSA, mm2 | 7.5 ± 3.1 | 8.1 ± 3.2 | 0.97 |
Plaque burden, % | 53.2 ± 9.80 | 55.0 ± 9.30 | 0.67 |
Proximal segment of stent | |||
EEM CSA, mm2 | 13.3 ± 4.30 | 15.4 ± 3.40 | 0.56 |
Stent area, mm2 | 6.4 ± 2.1 | 8.6 ± 1.9 | 0.65 |
Lumen CSA, mm2 | 5.0 ± 1.6 | 5.9 ± 2.4 | 0.40 |
Neointimal CSA, mm2 | 1.2 ± 1.6 | 2.7 ± 1.9 | 0.66 |
Minimum lumen site | |||
EEM CSA, mm2 | 13.1 ± 4.40 | 12.9 ± 4.70 | 0.60 |
Stent area, mm2 | 5.9 ± 2.6 | 7.0 ± 0.6 | 0.11 |
Lumen CSA, mm2 | 2.2 ± 0.6 | 2.4 ± 0.8 | 0.18 |
Neointimal CSA, mm2 | 3.6 ± 2.3 | 4.6 ± 1.2 | 0.30 |
Neointimal hyperplasia, % | 55.7 ± 19.4 | 65.4 ± 14.5 | 0.48 |
Minimum stent site | |||
EEM CSA, mm2 | 13.2 ± 3.90 | 14.3 ± 4.20 | 0.91 |
Stent area, mm2 | 5.5 ± 2.7 | 6.7 ± 0.3 | 0.06 |
Lumen CSA, mm2 | 2.5 ± 0.8 | 2.8 ± 0.9 | 0.52 |
Neointimal CSA, mm2 | 2.9 ± 0.8 | 4.0 ± 0.7 | 0.05 |
Neointimal hyperplasia, % | 46.0 ± 24.9 | 59.4 ± 12.0 | 0.04 |
Stent under-expansion | 24 (48) | 0 (0) | 0.02 |
Distal segment of stent | |||
EEM CSA, mm2 | 12.3 ± 4.40 | 12.9 ± 3.90 | 0.93 |
Stent area, mm2 | 6.4 ± 2.4 | 7.0 ± 1.2 | 0.30 |
Lumen CSA, mm2 | 5.2 ± 1.9 | 6.2 ± 1.3 | 0.55 |
Neointimal CSA, mm2 | 1.2 ± 1.6 | 0.8 ± 0.4 | 0.31 |
Distal reference segment | |||
EEM CSA, mm2 | 11.8 ± 5.4 | 11.7 ± 5.4 | 0.75 |
Lumen CSA, mm2 | 6.0 ± 2.2 | 6.0 ± 1.0 | 0.14 |
P&M CSA, mm2 | 5.8 ± 3.5 | 5.6 ± 4.4 | 0.30 |
Plaque burden, % | 47.8 ± 8.30 | 41.7 ± 18.9 | 0.05 |
Lesion length | 12.8 ± 7.10 | 19.0 ± 3.20 | 0.34 |
*χ2-test for no event group vs. event group; p-value was calculated by χ2 - test for continuous (p-value < 0.05). CSA: Cross-sectional area, EEM: External elastic membrane, P & M: Plaque and media.